To, K. K. W., Tolu, S. S., Wang, L., Zhang, H., Cho, W. C., & Bates, S. E. (2025). HDAC inhibitors: Cardiotoxicity and paradoxical cardioprotective effect in ischemia-reperfusion myocardiocyte injury. Seminars in Cancer Biology, 113, 25–38. https://doi.org/10.1016/j.semcancer.2025.05.008

Liu, Y., & Gu, W. (2022). The complexity of p53-mediated metabolic regulation in tumor suppression. Seminars in Cancer Biology, 85, 4–32. https://doi.org/10.1016/j.semcancer.2021.03.010

Meggendorfer, M., Jobanputra, V., Wrzeszczynski, K. O., Roepman, P., de Bruijn, E., Cuppen, E., Buttner, R., Caldas, C., Grimmond, S., Mullighan, C. G., Elemento, O., Rosenquist, R., Schuh, A., & Haferlach, T. (2022). Analytical demands to use whole-genome sequencing in precision oncology. Seminars in Cancer Biology, 84, 16–22. https://doi.org/10.1016/j.semcancer.2021.06.009

Jobanputra, V., Wrzeszczynski, K. O., Buttner, R., Caldas, C., Cuppen, E., Grimmond, S., Haferlach, T., Mullighan, C., Schuh, A., & Elemento, O. (2022). Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology. Seminars in Cancer Biology, 84, 23–31. https://doi.org/10.1016/j.semcancer.2021.07.003

Rosenquist, R., Cuppen, E., Buettner, R., Caldas, C., Dreau, H., Elemento, O., Frederix, G., Grimmond, S., Haferlach, T., Jobanputra, V., Meggendorfer, M., Mullighan, C. G., Wordsworth, S., & Schuh, A. (2022). Clinical utility of whole-genome sequencing in precision oncology. Seminars in Cancer Biology, 84, 32–39. https://doi.org/10.1016/j.semcancer.2021.06.018

Li, W., & Shen, M. M. (2022). Prostate cancer cell heterogeneity and plasticity: Insights from studies of genetically-engineered mouse models. Seminars in Cancer Biology, 82, 60–67. https://doi.org/10.1016/j.semcancer.2021.06.016

Calaf, G. M. (2021). Role of organophosphorous pesticides and acetylcholine in breast carcinogenesis. Seminars in Cancer Biology, 76, 206–217. https://doi.org/10.1016/j.semcancer.2021.03.016